A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/1997
10/29/1997	EP0802901A1 Novel carbamate compounds containing thiocarbamoyl group and process for preparing the same
10/29/1997	EP0802899A1 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane
10/29/1997	EP0802800A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
10/29/1997	EP0802797A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
10/29/1997	EP0759744A4 Narcotic containing aerosol formulation
10/29/1997	EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/29/1997	CN1163613A 7-azabicyclo£2,2,1\|-heptane and heptene derivatives as cholinergic receptor ligands
10/29/1997	CN1163563A Liposome composition containing selegilin
10/29/1997	CN1163139A Pill for tranquilizing and curing mania and its preparing method
10/29/1997	CN1163135A Dredging liquid for channels and collateralls
10/29/1997	CN1163132A Oral liquor for giving up drug
10/28/1997	US5681965 Alpha-phenyl tert-butyl nitrone and derivatives as free radical scavengers treating aging, oxidative tissue damage
10/28/1997	US5681956 Useful in diagnosis and treatment of schizophrenia and depression as well as parkinsonism
10/28/1997	US5681861 Aminoguanidines and methods of use of same
10/28/1997	US5681833 Benzodiazepine derivatives
10/28/1997	US5681590 Dry mix formulation for bisphosphonic acids
10/28/1997	US5681568 Device for delivery of substances and methods of use thereof
10/23/1997	WO1997039123A2 Secreted proteins
10/23/1997	WO1997039032A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/23/1997	WO1997039024A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/23/1997	WO1997039001A1 Isoxazolidine derivatives
10/23/1997	WO1997038993A1 Isatin derivatives as acetylcholinesterase inhibitors and analgesics
10/23/1997	WO1997038991A1 Substituted tetracyclic tetrahydrofuran derivatives
10/23/1997	WO1997038990A1 Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
10/23/1997	WO1997038989A1 N-aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands
10/23/1997	WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997	WO1997038724A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
10/23/1997	WO1997038682A1 Biphenylamido derivatives as melatonergic agents
10/23/1997	WO1997038675A1 New pharmaceutical composition with anaesthetic effect
10/23/1997	WO1997026853A3 Dna encoding galanin galr2 receptors and uses thereof
10/23/1997	DE19615232A1 Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten New carbamoyl derivatives and their use as 5-HT antagonists ¶1¶¶A¶
10/23/1997	CA2251930A1 Biphenylamido derivatives as melatonergic agents
10/23/1997	CA2251814A1 N-aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands
10/23/1997	CA2224859A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/23/1997	CA2219151A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/22/1997	EP0802195A2 Substituted 2,3-benzodiazepine derivatives, process and intermediates for their preparation and pharmaceutical compositions comprising them as well as their use
10/22/1997	EP0801946A2 Use of salicin as agent against irritation in cosmetic and topical dermatological compositions
10/22/1997	EP0801945A2 Use of ferulic acid glucosides as agents against irritation in cosmetic or topical dermatological compositions
10/22/1997	EP0801679A1 Monoclonal antibodies which promote central nervous system remyelination
10/22/1997	EP0801651A1 Hydroxymethylimidazodiazepines and their esters
10/22/1997	EP0801649A2 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
10/22/1997	EP0801646A1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
10/22/1997	EP0801642A1 Novel sulfamate compound containing n-substituted carbamoyl group and method for preparing the same
10/22/1997	EP0801527A1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
10/22/1997	EP0660819B1 New n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds
10/22/1997	EP0640080B1 Substituted indoles as angiotensin ii antagonists
10/22/1997	CN1162957A Isoxazoles
10/22/1997	CN1162599A Process for manufacture of imidazodiazepine derivatives
10/21/1997	US5679711 Hydroxyl ions as novel therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents
10/21/1997	US5679686 Antipsychotic method
10/21/1997	US5679680 α-substituted hydrazides having calpain inhibitory activity
10/21/1997	US5679678 Analgesic and antiinflammatory agents
10/21/1997	US5679674 Analgesics
10/21/1997	US5679663 Hydrazides of phosphinic acid derivatives; used as anti-depressant and memory enhancement
10/21/1997	US5679660 Pharmaceutical composition comprising diclofenac and cyclodextrin
10/21/1997	US5679650 Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
10/21/1997	US5679531 Methods of detecting βA4 peptide species ending at carboxy-terminus residue 42 using monoclonal antibody 369.2B
10/21/1997	US5679530 Immunogenic complex of isolated polypeptides of specific amino acid sequence to a keyhole lampet hemocyanin
10/21/1997	US5679339 Method of using IL-11 for treating spondyloarthropies
10/16/1997	WO1997038084A2 Polynucleotides derived from a pbmc cdna library encoding secreted proteins
10/16/1997	WO1997038008A1 6-substituted amino-4-oxa-1-azabicyclo[3,2,0] heptan-7-one deriv atives as cysteine protease inhibitors
10/16/1997	WO1997038007A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997	WO1997038004A1 Gene family associated with neurosensory defects
10/16/1997	WO1997037992A2 Spiro[cyclopent[b]indole-piperidines] and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors
10/16/1997	WO1997037974A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	WO1997037973A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	WO1997037972A1 Novel vitamin d analogues
10/16/1997	WO1997037689A2 Denaturants for sympathomimetic amine salts
10/16/1997	WO1997037688A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
10/16/1997	WO1997037664A2 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997	WO1997037652A1 Methods of providing neuroprotection
10/16/1997	WO1997037648A1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
10/16/1997	WO1997037630A2 Spiro(2h-1-benzopyran-2,4'-piperidine)-4(3h)-one derivatives, acid addition salts thereof and pharmaceutical compositions containing them
10/16/1997	WO1997030178A3 Diagnosing trinucleotide repeat diseases and genes involved therein
10/16/1997	WO1997022619A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
10/16/1997	CA2650637A1 Pharmaceutical composition containing angiotensin ii antagonist
10/16/1997	CA2252086A1 6-substituted amino-4-oxa-1-azabicyclo¬3,2,0\|heptan-7-one derivatives as cysteine protease inhibitors
10/16/1997	CA2251603A1 Gene family associated with neurosensory defects
10/16/1997	CA2251579A1 Methods of providing neuroprotection
10/16/1997	CA2250874A1 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997	CA2250860A1 Polynucleotides encoding secreted proteins
10/16/1997	CA2250755A1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
10/16/1997	CA2248949A1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof
10/16/1997	CA2248082A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997	CA2248070A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	CA2247964A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	CA2224212A1 Novel spiro (2h-1-benzopyran-2,4'-piperidine)- 4(3h)-one derivatives, acid addition salts thereof and pharmaceutical compositions containing them
10/15/1997	EP0801060A1 Heterocyclic Beta-3 Adrenergenic Agonists
10/15/1997	EP0800584A1 Arachidonic acid and methods for the production and use thereof
10/15/1997	EP0800535A1 Fibronectin adhesion inhibitors
10/15/1997	EP0800534A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/15/1997	EP0800532A1 Improved cyclic crf agonists
10/15/1997	EP0800528A1 Peptide and peptide analog protease inhibitors
10/15/1997	EP0800520A1 Process for the preparation of lamotrigine
10/15/1997	EP0800515A1 DIBENZ cd,f]INDOLE DERIVATIVES
10/15/1997	EP0800503A1 Novel trienoic retinoid compounds and methods
10/15/1997	EP0546102B1 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases
10/15/1997	EP0537269B1 Immunosuppressive compounds
10/15/1997	CN1162313A Substituted tetracyclic azepine derivatives having affinity for 5-HT2 receptors
10/15/1997	CN1162266A Novel brain endothelial cell protein and methods for its use

1 ... 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 ... 1833